semaglutide for weight loss twin falls id Injections Kirkland & Bellevue Semaglutide for weight loss |

Medically Unsuitable Alternatives: There must be a clinical reason why an existing FDA-approved drug cannot be used for certain patients

Dosing schedule per ALLUVI instructions: Weeks 14 (starting dose): 2.5 mg once weekly Weeks 58: 5 mg once weekly Weeks 913: 7.5 mg once weekly Weeks 14+: 10 mg once weekly Do not increase dose until hunger sensation returns

Consequently, researchers observe a significantly extended half-life (estimated between 20 to 30 hours) and substantially increased biological potency in vitro

Tirzepatide works on two different mechanisms in the body to do a very similar thingmake you feel fuller. The key differences include: Semaglutide (Ozempic/Wegovy) works through one mechanism and was first to market Tirzepatide (Mounjaro) works through two mechanisms, potentially offering better weight loss results with fewer side effects Tirzepatide tends to be more expensive and less likely to be covered by insurance Semaglutides patent has expired, allowing compounding pharmacies to continue producing it regardless of FDA decisions This distinction explains why compounding pharmacies can continue offering semaglutide while tirzepatide remains in regulatory limbo

CJC-1295 is a GHRH analog that promotes sustained, physiologic growth hormone pulses from the pituitary

This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietitian, on 3 September 2025